Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710150016 | Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3710151017 | Glimepiride- and pioglitazone-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Is a | Product containing pioglitazone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Is a | Product containing glimepiride in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Is a | Product containing glimepiride and pioglitazone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Has active ingredient | Pioglitazone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Has active ingredient | Glimepiride | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet | Is a | False | Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet | Is a | False | Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only glimepiride and pioglitazone in oral dose form (medicinal product form) | Is a | True | Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR